We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast ...

Investors with a lot of money to spend have taken a bearish stance on Icon (NASDAQ:ICLR). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Research suggests that a compound in pomegranates may rejuvenate our cells, boosting immunity and muscles. Food and cosmetic ...

reinforcing FDA guidance for patient-centered study design and execution Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on TScan Therapeutics (TCRX – Research Report), with ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease ...

The diabetes meds in question are called GLP-1 RAs (sometimes abbreviated as GLP-1s). They include diabetes meds like ...

Marinus Pharmaceuticals sells a drug to reduce seizures in people with a rare genetic disorder. Recently, a study showed the ...

GE HealthCare's AI initiatives, including AI-powered imaging solutions and strategic partnerships, are led by its chief AI ...